Congenital hyperinsulinism: Pancreatic [18F]fluoro-L- dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 933-940

  De Lonlay, Pascale ^a   Simon Carre, Aurore ^a   Ribeiro, Maria João ^b   Boddaert, Nathalie ^a   Giurgea, Irina ^a   Laborde, Kathleen ^a   Bellanné Chantelot, Christine ^c   Verkarre, Virginie ^a   Polak, Michel ^a   Rahier, Jacques ^d   Syrota, André ^b   Seidenwurm, David ^e   Nihoul Fékété, Claire ^a   Robert, Jean Jacques ^a   Brunelle, Francis ^a   Jaubert, Francis ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e Radiological Associates of Sacramento Medical Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA; DOPAMINE; FLUORINE 18; FLUORODIHYDROXYPHENYLALANINE F 18; INSULIN; PROINSULIN; TRACER; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN INS 1; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG METABOLISM; DRUG UPTAKE; ENZYME ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFANT; INSULIN RELEASE; PANCREAS ISLET; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; CELL LINE; CHILD; CHILD, PRESCHOOL; DIHYDROXYPHENYLALANINE; DOPA DECARBOXYLASE; FLUORINE RADIOISOTOPES; HUMANS; HYPERINSULINISM; IMMUNOHISTOCHEMISTRY; INFANT; INSULIN; ISLETS OF LANGERHANS; PANCREAS; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 33644826785     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1713     Document Type: Article

References (46)

1. Pagliara AS, Karl IE, Haymond M, Kipnis DM 1973 Hypoglycemia in infancy and childhood. I. J Pediatr 82:365-379
2. Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK 1990 Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics 85:834-837
3. Aynsley-Green A, Hussain K, Hall J, Hall J, Saudubray JM, Nihoul-Fekete C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P, Lindley KJ 2000 Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 82:F98-F107
4. Thomas Jr CG, Underwood LE, Carney CN, Dolcourt JL, Whitt JJ 1977 Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg 185:505-517
5. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fekete C, Robert JJ, Saudubray JM 1999 Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 340:1169-1175
6. Rahier J, Sempoux C, Fournet JC, Poggi F, Brunelle F, Nihoul-Fekete C, Saudubray JM, Jaubert F 1998 Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology 32:15-19
7. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ 2004 Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 84:239-275
8. de Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, Delagne V, Mayaud C, Chigot V, Sempoux C, Brusset MC, Laborde K, Bellane-Chantelot C, Vassault A, Rahier J, Junien C, Brunelle F, Nihoul-Fekete C, Saudubray JM, Robert JJ. 2002 Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 161:37-48
9. Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H 1995 Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 80:386-392
10. Dubois J, Brunelle F, Touati G, Sebag G, Nuttin C, Thach T, Nikoul-Fekete C, Rahier J, Saudubray JM 1995 Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 25:512-516
11. Giurgea I, Laborde K, Touati G, Bellanne-Chantelot C, Nassogne MC, Sempoux C, Jaubert F, Khoa N, Chigot V, Rahier J, Brunelle F, Nihoul-Fekete C, Dunne MJ, Stanley C, Saudubray JM, Robert JJ, de Lonlay P 2004 Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. J Clin Endocrinol Metab 89:925-929
12. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, Steinkrauss L, Wanner L, Kaye R, Ruchelli E, Suchi M, Adzick NS 2004 Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 89:288-296
13. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dolle F, Nihoul-Fekete C, Syrota A, Brunelle F 2005 Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-l-DOPA. J Nucl Med 46:560-566
14. Otonkoski T, Nanto-Salonen K, Seppanen M, Veijola R, Huopio H, Hussain K, Tapanainen P, Eskola O, Parkkola R, Ekstrom K, Guiot Y, Rahier J, Laakso M, Rintala R, Nuutila P, Minn H 2006 Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 55:13-18
15. Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, Moser E, Nitzsche E 2001 Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 220:373-380
16. Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP 2002 Pheochromocytomas: detection with 18F DOPA whole body PET - initial results. Radiology 222:507-512
17. Rodriguez MJ, Saura J, Finch CC, Mahy N, Billett EE 2000 Localization of monoamine oxidase A and B in human pancreas, thyroid, and adrenal glands. J Histochem Cytochem 48:147-151
18. Orlefors H, Sundin A, Fasth KJ, Oberg K, Langstrom B, Eriksson B, Bergstrom M 2003 Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine. Nucl Med Biol 30:669-679
19. Lindstrom P 1986 Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets. Biochim Biophys Acta 884:276-281
20. Borelli MI, Villar MJ, Orezzoli A, Gagliardino JJ 1997 Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab 23:161-163
21. Ericson LE, Hakanson R, Lundquist I 1977 Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 13:117-124
22. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
23. Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S 1984 The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 26:282-289
24. Lindstrom P, Sehlin J 1987 Effects of substrates for aromatic l-amino acid decarboxylase on insulin secretion. Acta Endocrinol (Copenh) 116:21-26
25. Hornykiewicz O 2002 L -DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids 23:65-70
26. Jetton TL, Liang Y, Cincotta AH 2001 Systemic treatment with sympatholytic dopamine agonists improves aberrant β-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Metabolism 50:1377-1384
27. Ahren B 2000 Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 43:393-410
28. Konturek SJ, Zabielski R, Konturek JW, Czarnecki J 2003 Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol 481:1-14
29. Berlan M, Montastruc JL, Lafontan M 1992 Pharmacological prospects for α2-adrenoceptor antagonist therapy. Trends Pharmacol Sci 13:277-282
30. Lemmer K, Ahnert-Hilger G, Hopfner M, Hoegerle S, Faiss S, Grabowski P, Jockers-Scherubl M, Riecken EO, Zeitz M, Scherubl H 2002 Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sci 71:667-678
31. Alm P, Ehinger B, Falck B 1969 Histochemical studies on the metabolism of L-DOPA and some related substances in the exocrine pancreas. Acta Physiol Scand 76:106-120
32. Mezey E, Eisenhofer G, Harta G, Hansson S, Gould L, Hunyady B, Hoffman BJ 1996 A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci USA 93:10377-10382
33. Teitelman G 1993 On the origin of pancreatic endocrine cells, proliferation and neoplastic transformation. Tumour Biol 14:167-173
34. Iturriza FC, Thibault J 1993 Immunohistochemical investigation of tyrosine-hydroxylase in the islets of Langerhans of adult mice, rats and guinea pigs. Neuroendocrinology 57:476-480
35. Stenstrom A, Panagiotidis G, Lundquist I 1989 Monoamine oxidase (MAO) in pancreatic islets of the mouse: some characteristics and the effect of chemical sympathectomy. Diabetes Res 11:81-84
36. Pearse AG 1969 The calcitonin secreting C cells and their relationship to the APUD cell series. J Endocrinol 45(Suppl):13-14
37. Rorsman P, Renstrom E 2003 Insulin granule dynamics in pancreatic β cells. Diabetologia 46:1029-1045
38. Avshalumov MV, Rice ME 2003 Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci USA 100:11729-11734
39. Avshalumov MV, Chen BT, Marshall SP, Pena DM, Rice ME 2003 Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2. J Neurosci 23:2744-2750
40. Dao D, Frank D, Qian N, O'Keefe D, Vosatka RJ, Walsh CP, Tycko B 1998 IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet 7:597-608
41. Lee MP, Reeves C, Schmitt A, Su K, Connors TD, Hu RJ, Brandenburg S, Lee MJ, Miller G, Feinberg AP 1998 Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res 58:4155-4159
42. Reece M, Prawitt D, Landers J, Kast C, Gros P, Housman D, Zabel BU, Pelletier J 1998 Functional characterization of ORCTL2 - an organic cation transporter expressed in the renal proximal tubules. FEBS Lett 433:245-250
43. Dong Y, Cooper D, Nasif F, Hu XT, White FJ 2004 Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons. J Neurosci 24:3077-3085
44. Liu Y, He HR, Ding JH, Gu B, Wang H, Hu G 2003 Iptkalim inhibits cocaine challenge-induced enhancement of dopamine levels in nucleus accumbens and striatum of rats by up-regulating Kir6.1 and Kir6.2 mRNA expression. Acta Pharmacol Sin 24:527-533
45. Liss B, Neu A, Roeper J 1999 The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. J Neurosci 19:8839-8848
46. Geng X, Li L, Watkins S, Robbins PD, Drain P 2003 The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas. Diabetes 52:767-776